Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
Tsuyoshi HaradaTetsuya TsujiJunya UenoYu KoishiharaNobuko KonishiNanako HijikataAiko IshikawaDaisuke KotaniTakashi KojimaHisashi FujiwaraTakeo FujitaPublished in: Annals of surgical oncology (2022)
Major SMI loss has an impact on OS after R0 curative esophagectomy for older patients with locally advanced esophageal cancer.